2invest
Heidelberg, Germany3
14M
2
0.33
- Areas of investment
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Simulation (2)
- Therapeutics (2)
- Translation Service (2)
- Life Science (1) Show 1 more
- Investments by region
- Italy (1)
- United Kingdom (2)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| NeoPhore | 01 Feb 2024 | Biotechnology, Therapeutics, Simulation, Translation Service | Early Stage Venture | 13M | England, Cambridge, United Kingdom |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Rad AI | May 20, 2025 | Generative AI, Healthcare, Healthcare AI, Radiology, Radiology Solutions | - | 8000000 USD |  San Francisco, California |
| Capital Rx | Nov 10, 2023 | Claims Processing Platform, Cloud-native, Cloud-native Technology, Healthcare Technology, Health Technology, Medicare, Medicaid, and Commercial Plans, Pharmacy Benefit Administrator, Pharmacy Benefit Manager, Pharmacy Platform | - | 50000000 USD | New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.